You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Dosing and administration of
Relvar Ellipta

Inhalation only. One inhalation once daily of Relvar Ellipta taken at the same time every day[1].

How to use the Ellipta® Inhaler

These instructions are designed to help show your patients how to use the Ellipta inhaler.

Order an Ellipta How to Use tear pad, a pack of 50.

Download a printer friendy version for patients.

Only open the package when you are ready to begin using your inhaler. Once you tear open the foil you should use your Ellipta inhaler within 6 weeks. The “Discard by” date should be written on the inhaler label in the space provided. The “Discard by” date is 6 weeks from the date of opening the tray. After this date the inhaler should no longer be used. The tray can be discarded after first opening. The printer friendly version above includes a space for patients to write down this information.

Open Ellipta


  • Slide the cover down until you hear a ‘click

  • While holding the inhaler away from your mouth, breathe out as far as is comfortable
Ellipta inhale


  • Put the mouthpiece between your lips, and close your lips firmly around it

  • Take one long, steady, deep breath in and hold this breath for at least 3-4 seconds


Ellipta close


  • Remove the inhaler from your mouth and breathe out slowly and gently

  • Slide the cover upwards as far as it will go to cover the mouthpiece

  • It is not necessary to clean the mouthpiece. If you choose to do so, always use a dry tissue

IMPORTANT: The demonstration Ellipta inhaler is intended for demonstrating only and not for patient use. Patients should not put the demonstration inhaler in their mouth.

How to use the Ellipta inhaler video

Watch our short video on how to use the Ellipta inhaler.

Video player requires JavaScript enabled. You can download this video here:

Note: The Ellipta demonstration inhaler should be replaced once the dose counter reaches zero. Used Ellipta inhalers can be recycled and recovered through the Complete the Cycle scheme. To find your nearest participating pharmacy visit

Getting Started

Before your patient starts using their active inhaler, you should consider the following:

The Ellipta® demonstration inhaler is packaged in a tray containing a dessicant gel sachet, which should be thrown away with the other packaging.

When it is taken out of the tray, the inhaler will be in the ‘closed’ position (the cover will be shut). It is ready to use straight from the packaging, so there is no need to prepare it for use in any special way. 

IMPORTANT: If your patient opens and closes the cover of their inhaler without inhaling the medicine, the dose will be lost. Your patient should be ready to take the medicine before opening the cover.

Please note:

  • It may not be possible to taste or feel the medicine, even when using the inhaler correctly
  • Do not shake the inhaler, block the air vents with your fingers, or breathe out into the inhaler
  • The dose counter will count down by one unit at a time. If the dose counter does not count down when you hear the ‘click’, the inhaler will not deliver the required dose. If this happens, your patient should take the inhaler back to the pharmacy.
Innoviva logo

Adverse events should be reported. Reporting forms and information can be found at
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

Relvar, Incruse and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies